Kevin C. Gorman
2018
Compensation breakdown
| Bonus | $425,250 |
|---|---|
| Option Awards | $4,486,852 |
| Salary | $675,000 |
| Stock Awards | $2,998,832 |
| Other | $47,045 |
| Total | $8,632,979 |
Gorman received $4.5M in option awards, accounting for 52% of the total pay in 2018.
Gorman also received $425.3K in bonus, $675K in salary, $3M in stock awards and $47K in other compensation.
Rankings
In 2018, Kevin C. Gorman's compensation ranked 916th out of 14,244 executives tracked by ExecPay. In other words, Gorman earned more than 93.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 916 out of 14,244 | 94th |
Division Manufacturing | 307 out of 5,762 | 95th |
Major group Chemicals And Allied Products | 94 out of 2,125 | 96th |
Industry group Drugs | 72 out of 1,814 | 96th |
Industry Biological Products, Except Diagnostic Substances | 22 out of 339 | 94th |
Pay ratio
| Kevin C. Gorman's Pay | $8,632,979 |
|---|---|
| Median Employee's Pay | $259,000 |
| Pay Ratio | 33to 1 |
In 2018, the annual total compensation of Kevin C. Gorman was $8,632,979.
The annual total compensation of the median employee at Neurocrine Biosciences was $259,000.
The ratio of Kevin C. Gorman's pay to the pay of median employee was therefore 33 to one.
Gorman's colleagues
We found five more compensation records of executives who worked with Kevin C. Gorman at Neurocrine Biosciences in 2018.
2018
Eiry Roberts
Neurocrine Biosciences
Chief Medical Officer
2018
Kyle Gano
Neurocrine Biosciences
Chief Business Development Officer
2018
Eric Benevich
Neurocrine Biosciences
Chief Commercial Officer
2018
Haig Bozigian
Neurocrine Biosciences
Chief Development Officer
2018
Matthew Abernethy
Neurocrine Biosciences
Chief Financial Officer
News
April 7, 2022
April 9, 2021
April 9, 2020
April 17, 2019